A library of mutated EMCV IRES elements enables tunable expression of multiple genes in mammalian cells, which can optimize monoclonal antibody production and other synthetic biology applications.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for tunable multi-gene expression in biomanufacturing; leaves open scalability and in vivo validation.
A set of mutated Encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES) elements with varying strengths is generated by mutating the translation initiation codons of 10(th), 11(th), and 12(th) AUG to non-AUG triplets. They are able to control the relative expression of multiple genes over a wide range in mammalian cells in both transient and stable transfections. The relative strength of each IRES mutant remains similar in different mammalian cell lines and is not gene specific. The expressed proteins have correct molecular weights. Optimization of light chain over heavy chain expression by these IRES mutants enhances monoclonal antibody expression level and quality in stable transfections. Uses of this set of IRES mutants can be extended to other applications such as synthetic biology, investigating interactions between proteins and its complexes, cell engineering, multi-subunit protein production, gene therapy, and reprogramming of somatic cells into stem cells.
No takes yet. Share an insight, caveat, or question.
Koh et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: